Cytogenetic abnormalities are frequent in uncultured prostate cancer cells

Cancer Genetics and Cytogenetics

Volumn 88, Issue 2, 1996, Pages 126-132

  Webb, Heather D ^a   Hawkins, Anita L ^a   Griffin, Constance A ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CHROMOSOME 8P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOCHROMOSOME; KARYOTYPE; MALE; METAPHASE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0029977123     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00305-3     Document Type: Article

References (39)

1. Atkin NB and Baker MC (1985): Chromosome study of five cancers of the prostate. Hum Genet 70:359-364.
2. Lundgren R, Kristofersson U, Heim S, Mandahl N, Mitelman F (1988): Multiple structural chromosome rearrangements, including del(7q) and del(l0q), in an adenocarcinoma of the prostate. Cancer Genet Cytogenet 35: 103-108.
3. Brothman AR, Peehl DM, Patel A, McNeal JE (1990): Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50: 3795-3803.
4. Babu VR, Miles BJ, Cerny JC, Weiss L, Van Dyke DL (1990): Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet 48: 83-87.
5. Brothman AR, Peel DM, Patel AM, MacDonald GR, McNeal JE, Ladaga LE, Schellhammer PF (1991): Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 55: 79-84.
6. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR (1992): Cytogenetics of primary prostatic adenocarcinoma. Cancer Genet Cytogenet 61: 165-173.
7. Lundgren R, Mandahl, Heim S, Limon J, Henrikson H, Mitelman F (1992): Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chrom Cancer 4: 16-24.
8. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H (1993): Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet 66: 93-99.
9. Perlman EJ, Epstein JI, Long PP, Pizov G, Griffin CA (1993): Cytogenetic and ploidy analysis of prostatic adenocarcinoma. Modern Pathol 6: 348-352.
10. Limon J, Lundgren R, Elfving, P, Heim S, Kristoffersson U, Mandahl N, Mitelman F (1989): Double minutes in two primary adenocarcinomas of the prostate. Cancer Genet Cytogenet 39: 191-194.
11. Emmert-Buck MR, Vocke CD, Pozzatti RO, Duray PH, Jennings SB, Florence CD, Zhuang Z, Bostwick DG, Liotta LA, Linehan WM (1995): Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res 55: 2959-2962.
12. Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB (1993): Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53: 3869-3873.
13. Bergerheim USR, Kunimi K, Collins VP, Ekman P (1991): Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chrom Cancer 3: 215-220.
14. Carter BS, Ewing CM, Ward WS, Treiger BF, Alders TW, Schalken JA, Epstein JI, Isaacs WB (1990): Allelic loss of chromosomes 16q and 10q in human prostatic cancer. Proc Natl Acad Sci USA 87: 8751-8755.
15. Kunimi K, Bergerheim USR, Larsson I-L, Keman P, Collins VP (1991): Allelotyping of human prosatic adenocarcinoma. Genomics 11: 530-536.
16. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP (1995): Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55: 342-347.
17. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP (1994): Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol 145: 624-630.
18. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH (1995): Mapping of regions of physical delection on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 153: 249-254.
19. Breitkreuz T, Romanakis K, Lutz S, Seitz G, Bonkhoff H, Unteregger G, Zwergel T, Zang KD, Wullich B (1993): Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 53: 4035-4040.
20. Brothman AR, Watson MJ, Watson X, Zhu L, Williams BJ, Rohr LR (1994): Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH). Cancer Genet Cytogenet 75: 40-44.
21. Konig JJ, Teubel W, Van Donger WJ, Hagemeijer A, Romijn JC, Schroder FH (1993): Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chrom Cancer 8: 22-27.
22. Macoska JA, Micale MA, Sakr WA, Benson PD, Wolman SR (1993): Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis. Genes Chrom Cancer 8: 88-97.
23. Brothman AR, Patel AM, Peehl DM, Schellhammer PF (1992): Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 62: 180-185.
24. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR (1994): Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chrom Cancer 11: 163-170.
25. Brown JA, Alcaraz A, Takahashi S, Person DL, Lieber MM, Jenkins RB (1994): Chromosomal aneusomies detected by fluoresecent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 152: 1157-1162.
26. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson PD, Powell IJ, Pontes JE (1994): Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 54: 3824-3830.
27. ISCN (1991): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature, F. Mitelman, ed. S. Karger, Basel.
28. Heisterkamp N, Stam K, Groffen J (1985): Structural organization of the bcr gene and its role in the Ph translocation. Nature 315: 758-761.
29. Oshimura M, Sandberg AA (1975): Isochromosome 17 in a prostatic cancer. J Urol 114: 249-250.
30. Ahmann FR, Woo L, Hendrix M, Trent JM (1986): Growth in semisolid agar of prostate cancer cells obtained from bone marrow aspirates. Cancer Res 46: 3560-3564.
31. Gibas Z, Pontes JE, Sandberg AA (1985): Chromosome rearrangements in a metastatic adenocarcinoma of the prostate. Cancer Genet Cytogenet 16: 301-304.
32. Milasin J and Micic S (1994): Double minute chromosomes in an invasive adenocarcinoma of the prostate. Cancer Genet Cytogenet 72: 157-159.
33. Van Den Berg D, Guan X-Y, Von Hoff D, Jenkins R, Bittner M, Griffin C, Kallioniemi O, Visakorpi T, McGill J, Herath J, Epstein J, Sarosdy M, Meltzer P, Trent J (1995): DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res: 1: 11-18
34. Ohnuki Y, Marnell MM, Babcock MS, Lechner JF, Kaighn ME (1980): Chromosomal analysis of human prostatic adenocarcinoma cell lines. Cancer Res 40: 524:-534.
35. Konig JJ, Hagemeijer A, Smit B, Kamst E, Romijn JC, Schroder FH (1988): Characterization of an established xenografted prostatic adenocarcinoma cell line (PC-82). Cancer Genet Cytrogenet 34: 91-99.
36. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-Keller JJ, Lieber MM, Jenkins RB (1994): Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 54: 3998-4002.
37. Persons DL, Gibney DJ, Katzmann JA, Lieber MM, Farrow GM, Jenkins RB (1993): Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma. J Urol 150: 120-125.
38. Delattre O, Sucman J, Melot T, Garau XS, Zucker J-M, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G (1992): The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. Nature 359: 162-165.
39. Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW (1993): Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53: 5108-5112.